Finerenone (Kerendia, BAY948862)
Sponsors
Bayer
Conditions
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Unknown Phase
An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
CompletedNCT05703880
Start: 2023-06-01End: 2024-10-01Updated: 2024-10-18
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
Active, not recruitingNCT06608212
Start: 2024-10-09End: 2026-06-30Target: 150000Updated: 2026-07-01
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice
Active, not recruitingNCT06763146
Start: 2025-09-22End: 2026-09-30Target: 1200Updated: 2026-07-28
An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions in a Chinese Population.
CompletedNCT07124039
Start: 2025-07-16End: 2026-02-28Updated: 2026-04-14